Article info

Extended report
MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome

Authors

  1. Correspondence to Naomi Maria, Department of Immunology, Erasmus MC, Dr Molewaterplein 50, Rotterdam, Zuid-holland 3015 GE, The Netherlands; n.maria{at}erasmusmc.nl
View Full Text

Citation

Maria NI, Brkic Z, Waris M, et al
MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome

Publication history

  • Accepted March 19, 2013
  • First published July 6, 2013.
Online issue publication 
April 30, 2014

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.